Icoria to Commercialize Rosetta Genomics’ MicroRNA Technology
Icoria said last week that it has signed an agreement to commercialize Rosetta Genomics’ MirChip microRNA detection and analysis technology.
Icoria said the commercialization will take place through its Paradigm Array Labs unit. The launch of MirChip is slated for Oct. 26 at the American Society of Human Genetics meeting in Toronto.
Alnylam, Isis License MicroRNA Technology from Max Planck